Oneness Biotech Co., Ltd. (TPEX: 4743)

Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	839.7	812.83	5,655	332.96	217.64	166.56
Short-Term Investments	6,705	6,960	2,392	7,473	8,099	1,036
Trading Asset Securities	-	-	-	-	-	385.93
Cash & Short-Term Investments	7,545	7,773	8,047	7,806	8,317	1,588
Cash Growth	-8.85%	-3.40%	3.08%	-6.14%	423.69%	152.52%
Accounts Receivable	29.45	25.77	13.08	14.59	444.45	2.19
Other Receivables	66.38	50.77	19.86	114.2	70.37	15.01
Receivables	95.83	76.54	32.95	128.79	514.82	17.2
Inventory	118.1	122.74	111.4	81.32	50.19	48.35
Other Current Assets	57.85	45.93	42.2	35.31	55.31	34.82
Total Current Assets	7,817	8,018	8,233	8,051	8,937	1,689
Property, Plant & Equipment	1,162	1,195	1,033	1,038	1,046	991.69
Long-Term Investments	3,905	4,096	3,920	3,871	2,585	1,426
Goodwill	89.14	89.14	89.14	89.14	89.14	89.14
Other Intangible Assets	1,514	1,682	2,010	2,388	2,474	2,462
Long-Term Accounts Receivable	-	-	-	32.41	32.94	33.45
Long-Term Deferred Tax Assets	74.92	79.21	97.46	62.85	38.67	5.9
Other Long-Term Assets	194.9	204.05	197.65	197.86	180.73	282.58
Total Assets	14,757	15,364	15,580	15,731	15,384	6,980
Accounts Payable	2.41	1.7	1.52	2.5	48.43	0.61
Accrued Expenses	86.15	119.05	155.39	78.16	58.6	35.57
Current Portion of Leases	42.09	34.25	13.25	12.73	23.23	25.66
Current Income Taxes Payable	0.12	0.12	12.69	35.1	-	-
Other Current Liabilities	41.89	60.24	25.76	28.75	23.44	10.01
Total Current Liabilities	172.65	215.36	208.6	157.24	153.69	71.84
Long-Term Leases	383.82	397.95	250.09	270.34	279.86	302.65
Long-Term Unearned Revenue	174.11	176.07	145.99	1,155	1,155	145.99
Long-Term Deferred Tax Liabilities	76.56	76.56	95.22	58.18	35.09	-
Other Long-Term Liabilities	0.48	0.48	0.48	0.48	0.48	0.48
Total Liabilities	807.62	866.43	700.38	1,642	1,625	520.96
Common Stock	4,554	4,545	3,910	3,853	3,771	3,525
Additional Paid-In Capital	7,580	9,050	8,637	9,469	9,157	3,746
Retained Earnings	-265.51	-1,267	359.98	-1,036	-633.57	-422.2
Treasury Stock	-25.78	-25.78	-25.78	-47.38	-75.81	-75.81
Comprensive Income & Other	1,644	1,750	1,737	1,778	1,415	-445.88
Total Common Equity	13,486	14,053	14,618	14,016	13,633	6,327
Minority Interest	463.31	444.07	262.28	72.95	126.38	132.09
Shareholders' Equity	13,949	14,497	14,880	14,089	13,760	6,459
Total Liabilities & Equity	14,757	15,364	15,580	15,731	15,384	6,980
Total Debt	425.9	432.2	263.34	283.07	303.09	328.31
Net Cash (Debt)	7,119	7,341	7,783	7,523	8,014	1,260
Net Cash Growth	-11.22%	-5.69%	3.46%	-6.13%	536.11%	100.32%
Net Cash Per Share	14.93	15.51	16.50	16.52	18.80	4.20
Filing Date Shares Outstanding	477.12	476.23	466.02	458.4	447.43	418.05
Total Common Shares Outstanding	477.12	476.23	466.02	458.4	447.43	418.05
Working Capital	7,644	7,803	8,025	7,894	8,784	1,617
Book Value Per Share	28.27	29.51	31.37	30.58	30.47	15.13
Tangible Book Value	11,882	12,282	12,519	11,539	11,070	3,775
Tangible Book Value Per Share	24.90	25.79	26.86	25.17	24.74	9.03
Buildings	638.32	637.35	602.54	580.99	510.38	472.84
Machinery	554.63	555.2	522.99	456.01	399.52	260.92
Construction In Progress	16	-	-	13.03	48.15	76.15
Leasehold Improvements	45.79	38.15	14.56	14.01	9.16	7.9

Source: S&P Capital IQ. Standard template. Financial Sources.